Summary:
Kathawala also backed the need for stringent punishment to pharmaceutical companies indulging in fraudulent means. Sending out a "loud and clear message to the infamous fraternity of fraudsters and counterfeit drug manufacturers", the Bombay High Court on Friday imposed a penalty of Rs 1.50 crore on the owners of two pharmaceutical companies. However, when the court receiver visited the premises to seize the counterfeit products, it was found that several other products' trademarks of many pharmaceutical companies were being copied. Twin Impax and National Laboratories had violated the trademark rights of another pharmaceutical company named Shalina Laboratories Private Limited. Shalina Laboratories, which manufactures distributes and sells different products, had moved the court seeking to restrain copycat companies from using its trademark Tanzol..